Search

BHF researchers develop a heart ‘fingerprint’ to tailor personalised treatment for people at high risk of deadly heart attack.

Today the long-awaited results of a clinical trial for a new cholesterol-lowering drug were presented at a major cardiovascular conference in Washington.

Research we've funded, published in The Lancet Regional Health - Europe, has revealed the stark inequalities that exist in NHS heart care and how delays to care are costing lives.

We have teamed up with Menopause Mandate to increase awareness of women and heart conditions.

We've responded to latest NHS England figures which show a rise in the heart care waiting list, and that average ambulance response times for heart attacks and strokes remain nearly double the 18-minute target.

People affected by heart and circulatory disease have been helping to shape our work, by sharing their insight and experiences, and helping us to do all we can to meet the needs of those affected.

RESEARCH

University of Edinburgh | Professor David Newby

Doctors currently calculate a person’s risk of a future heart attack caused by coronary artery disease using a risk score based on a person’s age, gender and risk factors. If this score is high, doctors may suggest taking preventive measure...

Heart patients who experienced feelings of hopelessness had an increased risk of dying or suffering a heart attack, according to new research funded by us and presented at the British Cardiovascular Society.

Rosie was born with congenital heart disease. Her parents say that new VR technology, developed with funding from us, could improve the experiences of families like theirs.

Blood pressure-lowering medication can prevent serious cardiovascular conditions such as strokes, heart failure and heart attacks in adults with normal blood pressure, according to research we part-funded and that was published in The Lancet.